Abstract：Objective To analyze the distribution and drug resistance of pathogenic bacteria in patients with febrile neutropenic hematopathy in Luohu District of Shenzhen city.Methods The clinical data and drug sensitivity test results of 305 patients with febrile neutropenic hematopathy from June 2017 to December 2019 in Luohu District of Shenzhen City were retrospectively analyzed,and the distribution and drug resistance of pathogens were analyzed..Results Among the 305 cases of blood culture positive specimens,82 non-duplicative pathogenic bacteria were isolated,among which 61 were gram-negative bacteria,accounting for 74.39%,and Escherichia coli was the most,with 31 strains (37.80%).There were 18 gram-positive bacteria,accounting for 21.95%,and Coagulase-negative Staphylococcus was the most,8 strains (9.76%).There were three strains of fungus,accounting for 3.66%.The susceptibility test results showed that the resistance rates of Klebsiella pneumoniae and Escherichia coli to lactamase inhibitors were 40%-90%,but the resistance rates of Escherichia coli and Klebsiella pneumoniae to β lactamase inhibitors complex Piperacillin/Tazobactam were lower,6.00% and 11.00%,respectively.The drug resistance rates of Escherichia coli and Klebsiella pneumoniae to Amikacin were 25.50% and 12.30% respectively.The drug resistance rates of Escherichia coli and Klebsiella pneumoniae to Cefoxitin were 38.00% and 10.00%respectively.Klebsiellapneumoniae and Escherichia coli were highly sensitive to Meropenem and Imipenem.Pseudomonas aeruginosa was also highly sensitive to Meropenem and Imipenem,and the drug resistance rate to Piperacillin/Tazobactam,Cefepime,Aminoglycosides and Quinolones was 12.00%-26.00%.The drug resistance rate of Staphylococcus aureus to Erythromycin,Oxacillin and Penicillin antibacterial drugs was as high as 33.00%-100.00%.Coagulase-negative Staphylococcus had higher drug resistance than Staphylococcus aureus,reaching 44.00%-100.00%.Conclusions Gram negative bacteria are the main pathogens of patients with febrile neutropenic hematopathy in Luohu District of Shenzhen City,and they are highly sensitive to Meropenem and Imipenem.
钟小珍；韦洁宏；杨婷； 蔡毅华；郑文璇；覃桂芝；田琦；郝同雨. 深圳市罗湖区发热性中性粒细胞减少性血液病患者病原菌分布和耐药性分析[J]. 中国当代医药, 2020, 27(36): 167-170转177.
ZHONG Xiao-zhen； WEI Jie-hong；YANG Ting； CAI Yi-hua；ZHENG Wen-xuan； QIN Gui-zhi；TIAN Qi； HAO Tong-yu. Distribution and drug resistance of pathogenic bacteria in patients with febrile neutropenic hematopathy in Luohu District of Shenzhen City. 中国当代医药, 2020, 27(36): 167-170转177.
Peker N，Couto N，Sinha B，et al.Diagnosiso fbloodstream infections from positive blood cultures and directly from blood samples：recent developments in molecular approaches[J].Clin Microbiol Infect，2018，24（9）：944-955.
[2]
James RM，Phillips B.Fifteen-minute consultation：A guide to managing a child with a new finding of neutropenia[J].Arch Dis Child Educ Pract Ed，2019，104（6）：282-285.
[3]
Ferreira AM，Moreira F，Guimaraes T，et al.Epidemiology，risk factors and outcomes of multi-drug resistant bloodstream infections in hematopoietic stem cell transplant recipients：importance of previous gut colonisation[J].J Hosp Infect，2018，100（1）：83-91.
Kalil AC，Metersky ML，Klompas M，et al.Management of adults with hospital acquired and ventilator associated pneumonia：2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society[J].Clin Infect Dis，2016，63（5）：e61-e111.
[8]
尚红，王毓三，申子瑜.全国临床检验操作规程[M].北京：人民卫生出版社，2015.
[9]
Hawser SP，Badal RE，Bouchillon SK，et al.Comparison of CLSI 2009，CLSI 2010 and EUCAST cephalosporin clinical breakpoints in recent clinical isolates of Escherichia coli，Klebsiella pneumoniae and Klebsiella oxytoca from the SMART Global Surveillance Study[J].Int J Antimicrob Agents，2010，36（3）：293-294.
Yao JF，Li N，Jiang J.Clinical characteristics of bloodstream infections in pediatric acute leukemia：A singlecenter experience with 231 patients[J].Chin Med J，2017，130（17）：2076-2081.
京公网安备 11010502046607号